Novel CAR-T Cell Therapy to Be Studied in Blood, Breast Canc

A phase 1/1b trial will examine PRGN-3007 in patients with ROR1-positive hematologic and solid cancers.

Related Keywords

Precigen Ultra , Javier Pinilla Ibarz , Helen Sabzevari , National Institutes Of Health , National Institutes , What Can Patients With Cancer , Cll , Lymphoma , Leukemia , Breast Cancer , Clinical Trial Corner ,